Stay updated on REOLYSIN in KRAS Mutant CRC Clinical Trial
Sign up to get notified when there's something new on the REOLYSIN in KRAS Mutant CRC Clinical Trial page.

Latest updates to the REOLYSIN in KRAS Mutant CRC Clinical Trial page
- Check4 days agoChange DetectedThe page’s footer revision label was updated from v3.5.3 to v3.5.4, indicating a minor version update.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision tag changed from v3.5.2 to v3.5.3, indicating a small page version update rather than substantive changes to the study details.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedFooter revision indicators were updated: added Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check83 days agoChange DetectedNo additions or deletions were observed. The page content appears unchanged.SummaryDifference0.1%

Stay in the know with updates to REOLYSIN in KRAS Mutant CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REOLYSIN in KRAS Mutant CRC Clinical Trial page.